Nano-X Imaging Ltd filed a Form 6-K with the SEC on November 9, 2026, disclosing that its Board of Directors approved a strategic realignment and efficiency plan targeting a 25%-30% annualized reduction in operating expenses, alongside a global workforce reduction and four renewed strategic priorities.

Key Highlights

  • Expense reduction target: The plan is designed to achieve an annualized reduction of 25%-30% in GAAP and non-GAAP operating expenses compared to annualized 2026 operating expenses, excluding one-time restructuring-related charges.
  • Implementation timeline: The company currently expects full implementation to occur by the end of the first quarter of 2027.
  • Prior savings included: The targeted reduction includes approximately $2 million in annual cost savings previously announced in connection with the restructuring of the company's South Korea operations.
  • Workforce impact: The plan includes a reduction of the company's global workforce and other operational adjustments, according to the filing.
  • Going concern disclosure: The filing states that "substantial doubt exists about the Company's ability to continue as a going concern."
  • Nasdaq compliance: The company disclosed it is considering measures to regain compliance with Nasdaq's minimum bid price requirement.
  • Potential divestitures: The company is evaluating potential alternatives for its South Korea operations and certain other operations and assets, which may include divestitures, reductions in activity, or discontinuation of operations.

Nano-X Imaging Details Cost Reduction Plan and Strategic Priorities for 2027

According to the Form 6-K filed by Nano-X Imaging Ltd (NASDAQ:NNOX) on November 9, 2026, the Board of Directors approved a plan to reduce costs and improve operational efficiency, building on previously announced initiatives including the restructuring of the company's South Korea operations. The plan is intended to achieve an annualized 25%-30% reduction in GAAP and non-GAAP operating expenses relative to annualized 2026 levels, excluding one-time restructuring-related charges, once fully implemented by the end of the first quarter of 2027.

The filing states that the measures are expected to reduce the company's ongoing cash burn once fully implemented; however, the company cautioned that "restructuring-related payments may increase cash outflows in the near term." The company also disclosed it continues to review further opportunities to reduce expenses, including potential changes to manufacturing and supply chain arrangements, infrastructure expenditures, and other operational activities, which the filing describes as subject to further evaluation and, where applicable, required third-party or regulatory consent.

In addition to cost reduction measures, the filing outlines four strategic priorities: accelerating U.S. commercialization of Nanox.ARC and the Nanox Imaging Network; strengthening commercial partnerships including distribution relationships and exploring strategic opportunities for Nanox.AI and OEM capabilities; reducing operating costs while preserving critical capabilities; and evaluating financing and strategic alternatives. The filing further notes that the company expects it "will need to obtain additional financing, which may not be available on acceptable terms, or at all." The Form 6-K was signed by Erez Meltzer, Chief Executive Officer and Acting Chairman of the Board.

What Was Disclosed

Nano-X Imaging disclosed a Board-approved cost reduction and operational efficiency plan targeting a 25%-30% annualized operating expense reduction by end of Q1 2027, a global workforce reduction, potential asset divestitures, and an ongoing going concern warning alongside Nasdaq compliance concerns.